POLISCOPE
Back to feed
HR6732FEDERALIN_COMMITTEE
High Impact

Strengthening Innovation in Medicare and Medicaid Act (H.R. 6732)

Original title: Strengthening Innovation in Medicare and Medicaid Act

December 17, 2024

Track this bill to get notified when it advances a stage. One tap to stop, anytime.

Where This Stands

Introduced
Committee
Floor Vote
Passed
Signed

Currently IN_COMMITTEE. The next step in the legislative lifecycle is Floor Vote.

Version history

Only one version on file - nothing to compare yet. As later stages (committee substitute, engrossed, enrolled) are captured, the redline appears here.

View official text →

The Frame

What this does

The bill changes the rules for how Medicare and Medicaid test new healthcare delivery models, potentially limiting the scope of experimental programs and creating a new legislative pathway for Congress to block administrative changes to these programs.

Who is mentioned in the record

Potentially affected actors named in the source documents. Mention is not a position.

Medicare and Medicaid beneficiaries

The bill mandates real-time monitoring of models to mitigate potential reductions in care or access.

Healthcare providers and suppliers

Providers may request hardship waivers from model requirements and are subject to new reporting and participation rules.

Center for Medicare and Medicaid Innovation

The agency faces new caps on the number of models it can test and must adhere to new transparency and congressional oversight procedures.

What changed

Current stage: IN_COMMITTEE.

What's next

Floor Vote.

Summary

This bill places new limits and oversight requirements on the Center for Medicare and Medicaid Innovation (CMI) to control how it tests and expands new healthcare payment models. It requires the Secretary of Health and Human Services to implement hardship waivers for providers, increase public transparency, and establish a process for Congress to disapprove of new model expansions.

Key Facts

You don't have to trust us. Each fact below is taken straight from the official document - click any one to see the exact passage, highlighted in the original.

Frequently Asked Questions

How does this bill affect my Medicare coverage?
The bill requires the government to monitor new payment models for negative impacts on patient care and health disparities, and allows providers to request waivers if a model causes them undue economic hardship.
Can Congress stop new Medicare models from starting?
Yes, the bill creates a formal process for Congress to review and potentially block new model expansions via a within 45 days of receiving a proposal.
What is the 'Phase 1' limit?
Phase 1 testing of new models is now limited to 5 years and a maximum of 500,000 beneficiaries or 10% of the applicable population.

Why It Matters

The bill changes the rules for how Medicare and Medicaid test new healthcare delivery models, potentially limiting the scope of experimental programs and creating a new legislative pathway for Congress to block administrative changes to these programs.

News Coverage

No news coverage found yet. Articles are indexed twice daily.

Sponsors

Discoveries

Patterns POLISCOPE noticed across the record. These are observations to investigate, not conclusions.

policy shift100% confidence

Shift toward Congressional Oversight

The bill marks a clear attempt to move from administrative autonomy for CMI toward a model requiring explicit congressional approval for major program expansions.

Connected Entities

organizationCongressThe legislative bodyMap →
organizationCenter for Medicare and Medicaid Innovation (CMI)The agency responsible for testing innovative modelsMap →
otherSocial Security ActThe law under which Medicare and Medicaid operateMap →
personSmith of NebraskaIntroduced the bill in the House of RepresentativesMap →
personBuchananCo-sponsor of the billMap →
personWenstrupCo-sponsor of the billMap →

Analysis Score

0–100
  • Significance85
    How much this matters to a regular citizen
  • Controversy60
    Intensity of disagreement among stakeholders
  • Entertainment10
    Compellingness for a non-policy-wonk reader
  • Buzz30
    Current news / social attention level

Publisher tools

Share or embed this record

POLISCOPE publisher tools

Share or embed this record